| human | Q5 |
| P496 | ORCID iD | 0000-0002-4607-1176 |
| P735 | given name | Stephen | Q4927100 |
| Stephen | Q4927100 | ||
| P106 | occupation | researcher | Q1650915 |
| Q43068219 | A comparative study of the MATRICS and IntegNeuro cognitive assessment batteries. |
| Q35807939 | A novel once-daily fixed-dose combination of memantine extended release and donepezil for the treatment of moderate to severe Alzheimer's disease: two phase I studies in healthy volunteers |
| Q54026274 | Activation-related and activation-independent effects of polyamines on phencyclidine receptor binding within the N-methyl-D-aspartate receptor complex. |
| Q41452704 | Characterization of specific sigma opiate/phencyclidine (PCP)-binding sites in the human brain. |
| Q39917822 | Development of the synaptic glycine receptor in chick embryo spinal cord |
| Q67237653 | Differing stereospecificities distinguish opiate receptor subtypes |
| Q30999127 | Effect of cariprazine across the symptoms of mania in bipolar I disorder: Analyses of pooled data from phase II/III trials |
| Q48080525 | Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia: Results From an International, Phase III Clinical Trial. |
| Q35119680 | Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system. |
| Q41274014 | Glycine reverses 7-chlorokynurenic acid-induced inhibition of [3H]MK-801 binding. |
| Q52068970 | High-dose naloxone in tardive dyskinesia. |
| Q72408534 | Human platelets possess multiple [3H]imipramine binding sites |
| Q69685469 | Imipramine binding and cortisol in depression |
| Q48421523 | Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving |
| Q48672193 | Kinetic mechanisms of glycine requirement for N-methyl-d-aspartate channel activation |
| Q40643906 | Levomilnacipran Pharmacokinetics in Healthy Volunteers Versus Patients with Major Depressive Disorder and Implications for Norepinephrine and Serotonin Reuptake Inhibition |
| Q38331090 | Mechanisms of phencyclidine (PCP)-n-methyl-d-aspartate (NMDA) receptor interaction: implications for drug abuse research. |
| Q69855283 | Modulation of phencyclidine receptors by excitatory amino acid receptor ligands |
| Q48840787 | Ontogeny of sigma opiate/phencyclidine-binding sites in rat brain. |
| Q82313479 | P50 amplitude reduction: a nicotinic receptor-mediated deficit in first-degree relatives of schizophrenia patients |
| Q48552425 | Peripheral cocaine-blocking agents: new medications for cocaine dependence. An introduction to immunological and enzymatic approaches to treating cocaine dependence reported by Fox, Gorelick and Cohen in the immediately succeeding articles (see page |
| Q71879343 | Pharmacological augmentation of NMDA receptor function for treatment of schizophrenia |
| Q48640077 | Polyamine effects upon N-methyl-D-aspartate receptor functioning: differential alteration by glutamate and glycine site antagonists. |
| Q71607775 | Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial |
| Q45154158 | Rat brain N-methyl-D-aspartate receptors require multiple molecules of agonist for activation. |
| Q29618917 | Recent advances in the phencyclidine model of schizophrenia |
Search more.